Back
Keros Therapeutics Vs. GeneDx Holdings Industry Stock Comparison
Buy
60
KROS
Keros Therapeutics
Last Price:
59.64
Seasonality Move:
38.45%
Buy
73
WGS
GeneDx Holdings
Last Price:
83.19
Seasonality Move:
-27.57%
Buy
60
Keros Therapeutics (KROS)
is a Buy
Is Keros Therapeutics a Buy, Sell or Hold?
- The current Keros Therapeutics [KROS] share price is $60.14. The Score for KROS is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- KROS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
73
GeneDx Holdings (WGS)
is a Buy
Is GeneDx Holdings a Buy, Sell or Hold?
- The current GeneDx Holdings [WGS] share price is $84.10. The Score for WGS is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
- WGS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
KROS Stock Price Chart
What is Keros Therapeutics's stock price today?
-
The Keros Therapeutics share price today is $60.14
The current trend is moderately bullish and KROS is experiencing slight buying pressure.
WGS Stock Price Chart
What is GeneDx Holdings's stock price today?
-
The GeneDx Holdings share price today is $84.10
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and WGS is experiencing buying pressure, which is a positive indicator for future bullish movement.
KROS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.25 | Buy |
| Relative Strength Index (14 RSI): | 55.64 | Buy |
| Chaikin Money Flow: | 82977 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (57.66 - 61.04) | Buy |
| Bollinger Bands (100): | (45.18 - 57.08) | Buy |
WGS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 6.42 | Buy |
| Relative Strength Index (14 RSI): | 81.22 | Buy |
| Chaikin Money Flow: | 2788677 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (43.62 - 63.18) | Buy |
| Bollinger Bands (100): | (26.26 - 48.28) | Buy |
KROS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 60.01 | Buy |
| 20-day SMA: | 60.01 | Buy |
| 50-day SMA: | 55.19 | Buy |
| 200-day SMA: | 54.89 | Buy |
| 8-day EMA: | 60.09 | Buy |
| 20-day EMA: | 59.3 | Buy |
| 50-day EMA: | 56.32 | Buy |
| 200-day EMA: | 51.82 | Buy |
WGS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 61.27 | Buy |
| 20-day SMA: | 56.66 | Buy |
| 50-day SMA: | 44.31 | Buy |
| 200-day SMA: | 24.14 | Buy |
| 8-day EMA: | 63.44 | Buy |
| 20-day EMA: | 56.94 | Buy |
| 50-day EMA: | 47.55 | Buy |
| 200-day EMA: | 29.5 | Buy |
Keros Therapeutics Earnings Growth & KROS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.28 per share, and a decrease next year of $0.49 per share.
GeneDx Holdings Earnings Growth & WGS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.05 per share, and an increase next year of $0.53 per share.
Keros Therapeutics Technical Analysis
| Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 15 | 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
GeneDx Holdings Technical Analysis
| Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 15 | 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||